ORGO News and Press, Organogenesis Holdings Inc. From 05/09/24

CANTON, Mass., May 09, 2024 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical & Sports Medicine markets, today rep...

2024-05-08 17:35:55 ET Major earnings expected after the bell on Thursday include: Unity Software ( U ) Main Street Capital Corporation ( MAIN ) Marathon Digital Holdings ( MARA ) Wheaton Precious Metals Corp. ( WPM ) Blink Charging Co. ( BLNK ) ...

2024-05-08 17:35:08 ET More on Organogenesis Holdings Organogenesis Holdings, Inc. (ORGO) Q4 2023 Earnings Call Transcript Organogenesis Phase 3 ReNu OA study meets primary endpoint Cantor starts Organogenesis at overweight, cites differentiated portfolio See...

2024-05-02 11:56:00 ET More on Organogenesis Holdings Organogenesis Holdings, Inc. (ORGO) Q4 2023 Earnings Call Transcript Cantor starts Organogenesis at overweight, cites differentiated portfolio Seeking Alpha’s Quant Rating on Organogenesis Holdings ...

Statistically significant (p=0.0177) reduction in knee pain at six months Statistically significant (p<0.0001) maintenance of function at six months Transformational opportunity for Organogenesis to enter large and growing pain management market with innovative therapy ...

2024-04-25 13:06:40 ET Gainers: Loar Holdings ( LOAR ) +63% . Safe & Green Holdings Corp ( SGBX ) +61% . YY Group Holding Limited Class A Ordinary Shares ( YYGH ) +50% . Barfresh Food Group ( BRFH ) +40% . Processa Pharmaceuticals ( ...

2024-04-25 10:00:28 ET More on Health Care Select Sector SPDR XLV: Fundamentals Don't Support Overweighting Health Care XLV: Low-Cost Exposure To A Defensive Sector, While Achieving Strong Performance BofA watched clients retract $2B last week as the S&P dropped ...

CANTON, Mass., April 16, 2024 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical & Sports Medicine markets, today a...

2024-03-01 18:29:39 ET This earnings season, quite a few healthcare companies notched solid beats on revenue, earnings, or both. Unfortunately for its shareholders, Organogenesis Holdings (NASDAQ: ORGO) was not one of them. The wound care specialist published its fourth-quarter ...

2024-02-29 21:00:14 ET Image source: The Motley Fool. Organogenesis (NASDAQ: ORGO) Q4 2023 Earnings Call Feb 29, 2024 , 5:00 p.m. ET Operator Continue reading For further details see: Organogenesis (ORGO) Q4 2023 Earnings Call Transcript